- Home
- ALLO vs INSE Comparison
ALLO vs INSE Comparison
Compare ALLO & INSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLO
- INSE
- Stock Information
- Founded
- ALLO 2017
- INSE 2002
- Country
- ALLO United States
- INSE United States
- Employees
- ALLO N/A
- INSE N/A
- Industry
- ALLO Biotechnology: Biological Products (No Diagnostic Substances)
- INSE Computer Software: Prepackaged Software
- Sector
- ALLO Health Care
- INSE Technology
- Exchange
- ALLO Nasdaq
- INSE Nasdaq
- Market Cap
- ALLO 252.9M
- INSE 233.4M
- IPO Year
- ALLO 2018
- INSE N/A
- Fundamental
- Price
- ALLO $1.21
- INSE $8.00
- Analyst Decision
- ALLO Buy
- INSE Buy
- Analyst Count
- ALLO 12
- INSE 6
- Target Price
- ALLO $8.80
- INSE $13.50
- AVG Volume (30 Days)
- ALLO 2.9M
- INSE 98.9K
- Earning Date
- ALLO 11-13-2025
- INSE 11-05-2025
- Dividend Yield
- ALLO N/A
- INSE N/A
- EPS Growth
- ALLO N/A
- INSE N/A
- EPS
- ALLO N/A
- INSE 2.11
- Revenue
- ALLO N/A
- INSE $300,800,000.00
- Revenue This Year
- ALLO N/A
- INSE $4.50
- Revenue Next Year
- ALLO $100.00
- INSE N/A
- P/E Ratio
- ALLO N/A
- INSE $3.79
- Revenue Growth
- ALLO N/A
- INSE N/A
- 52 Week Low
- ALLO $0.86
- INSE $6.51
- 52 Week High
- ALLO $3.78
- INSE $11.61
- Technical
- Relative Strength Index (RSI)
- ALLO 49.04
- INSE 36.61
- Support Level
- ALLO $1.21
- INSE $7.82
- Resistance Level
- ALLO $1.26
- INSE $8.88
- Average True Range (ATR)
- ALLO 0.08
- INSE 0.46
- MACD
- ALLO -0.01
- INSE -0.03
- Stochastic Oscillator
- ALLO 14.18
- INSE 23.49
About ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.